Department of Pediatrics Archive — Page 18 of 55
-
April 4, 2023
Study shows ketamine could be beneficial for treating brain injury in children
Vanderbilt research shows a common anesthesia drug could be beneficial in reducing pressure inside the skull of children with traumatic brain injuries. -
March 30, 2023
Infant sleep safety education vital to reduce deaths
According to Tennessee’s 2022 Child Fatality Annual Report, over the past five years, white infants accounted for most of the sleep-related infant deaths in Tennessee, but Black infants were three times more likely to suffer a sleep-related fatality. -
March 30, 2023
Family’s gift will support pediatric cancer research
Lily Hensiek's family has made a new $1 million commitment to endow the Lily’s Garden Discovery Researcher Fund in the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Vanderbilt University Medical Center. -
March 23, 2023
Study sheds light on drug’s impact on diabetes progression
A Vanderbilt study of a treatment to delay the development of Type 1 diabetes in individuals at high risk did not meet the study goals of delaying progression from normal glucose tolerance to abnormal glucose tolerance or clinical diagnosis, although the study drug, abatacept, impacted immune response and preserved insulin production during the one-year treatment period. -
March 23, 2023
Poll shows food insecurity on rise in Tennessee
A newly released Vanderbilt poll found that an increasing number of Tennessee parents are reporting their families are food insecure. -
March 16, 2023
Study seeks to identify prenatal allergy risk markers
A Vanderbilt clinical trial is seeking to identify prenatal and early childhood markers of high risk for food allergy and atopic dermatitis, or eczema, as well as biological pathways that lead to these conditions. -
March 9, 2023
Family’s participation key to advancing diabetes research
A study of one family from Alabama has led Vanderbilt researchers to discover that insulin deficiency, independent of the autoimmunity associated with Type 1 diabetes, is the principal factor leading to a markedly smaller pancreas.